Peptide-Based Nanocomplexes Enable Transferrin-Mediated Uptake and p53-Driven Antitumor Activity in 2D and 3D Glioblastoma Models
International Journal of Molecular Sciences · 30.07.2026 · 27 (15) · 6857
DOI: 10.3390/ijms27156857 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.07.2026. Verfasst von Leonor M Castro und 5 weiteren Autor:innen. Beteiligte Einrichtung: RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Por…. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Suppressor Protein p53, Transferrin, Brain Neoplasms. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia.
Abstract (Originalsprache)
Glioblastoma (GB), the most prevalent and aggressive brain tumor, remains one of the most lethal challenges in modern oncology. Standard therapy remains largely ineffective, mainly due to limited therapeutic penetration across the blood–brain barrier (BBB) and adaptive tumor resistance. Consequently, there is an urgent need for innovative strategies to enhance therapeutic precision and efficacy. To address these limitations, we engineered a targeted peptide-based co-delivery system using the WRAP5 cell-penetrating peptide functionalized with a transferrin receptor (TfR)-targeting T7 peptide (sequence: HAIYPRH), enabling simultaneous delivery of temozolomide (TMZ) and a p53-encoding plasmid DNA. The resulting peptide-based TMZ/p53 nanocomplexes exhibited favorable physicochemical properties, enhanced TfR-mediated cellular uptake, and targeted antitumor activity mediated through p53-induced apoptosis in two-dimensional (2D) U87 MG cell cultures. To better reproduce the structural and cellular complexity of the tumor microenvironment, a three-dimensional U87 MG spheroid model was established and optimized using a Design of Experiments (DoE) approach to improve reproducibility and physiological relevance. The developed WRAP5-based nanocomplexes induced a significant dose-dependent inhibition of growth and morphological alterations in the U87 MG spheroid model, accompanied by deep penetration and cell death throughout the spheroid. Collectively, these findings highlight the potential of this targeted and tailored nanosystem to enhance cellular transfection, enable drug/gene co-delivery, restore p53 function, and promote apoptosis, representing a promising therapeutic strategy for GB treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RISE-Health, Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
- PhyMedExp, University of Montpellier, INSERM, CNRS, 34295 Montpellier, France.
ORCID-Profile: Leonor M Castro, Eric Vivès, Prisca Boisguérin, Ângela Sousa, Diana Costa
Förderung
- Fundação para a Ciência e Tecnologia
Zitieren
APA
Castro, L. M., Neves, A. R., Vivès, E., Boisguérin, P., Sousa, Â., & Costa, D. (2026). Peptide-Based Nanocomplexes Enable Transferrin-Mediated Uptake and p53-Driven Antitumor Activity in 2D and 3D Glioblastoma Models. International Journal of Molecular Sciences, 27(15), 6857. https://doi.org/10.3390/ijms27156857
Vancouver
Castro LM, Neves AR, Vivès E, Boisguérin P, Sousa Â, Costa D. Peptide-Based Nanocomplexes Enable Transferrin-Mediated Uptake and p53-Driven Antitumor Activity in 2D and 3D Glioblastoma Models. International Journal of Molecular Sciences. 2026;27(15):6857. doi:10.3390/ijms27156857
BibTeX
@article{Castro2026,
author = {Castro, Leonor M and Neves, Ana R and Vivès, Eric and Boisguérin, Prisca and Sousa, Ângela and Costa, Diana},
title = {Peptide-Based Nanocomplexes Enable Transferrin-Mediated Uptake and p53-Driven Antitumor Activity in 2D and 3D Glioblastoma Models},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6857},
doi = {10.3390/ijms27156857}
}
EUVIMED